General Dermatology

At AAD 2026, Maria-Angeliki Gkini, MD, PhD, shared guidance on diagnosing and managing topical steroid withdrawal syndrome.

Daniel C. Butler, MD, discusses adherence challenges, medication risks, and practical strategies to optimize dermatologic care in older adults.

This year’s AAD poster awards highlight studies advancing skin cancer prevention, inflammatory disease management, and complex dermatology care.

These leaders are shaping the future of dermatology through their clinical expertise, research, and educational presentations.

Guardrails and disclaimers are essential for responsible AI deployment in dermatology, according to Faranak Kamangar, MD.

Who is a woman who has shaped your life and career in dermatology? Hear stories from our experts as we celebrate Women's History Month 2026.

Overall, the future of dermatology lies in integrating innovation with individualized, evidence-based, and patient-centered care.

Twin experts reveal how dermatology and dentistry team up for facial aesthetics, early lesion detection, and safer care—from lasers to oral screenings.

In case you missed it, this week we had news on the FDA's approval of icotrokinra, phase 3 ADorable-1 data supporting lebrikizumab, the sBLA acceptance of tildrakizumab for PsA, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Aging hair fibers become finer in diameter, increasing vulnerability to chemical and physical damage.

When used thoughtfully, Faranak Kamangar, MD, says AI can transform generic processes into innovative, time-saving clinical tools.

Defined by emotional exhaustion, depersonalization, and reduced accomplishment, burnout goes beyond a difficult day in clinic.

Discover how physician-led dermatology practices build patient-first culture, drive innovation, and sustain long-term care in a changing health care market.

Women often present with sudden skin, hair, and vascular changes that may signal perimenopause rather than normal aging.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news on deucravacitinib's approval for PsA, AI-based tumor shape analysis in melanoma, QRX003's fast track for Netherton Syndrome, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

On National Dermatologist Day, EltaMD unveils oil-balancing UV Clear SPF 50, clinically reducing the appearance of blemishes, shine, and pore size. Learn more in this Q&A with Seemal R. Desai, MD, FAAD, and Annie Woo, MD.

On National Skin Barrier Day, dermatologists share barrier-saving tips for gentle cleansing, daily sunscreen, smarter product audits, and retinoid adherence.

A cover feature by Nicole A. Negbenebor, MD, FAAD, examines the growing leadership role of women in Mohs micrographic surgery for nonmelanoma skin cancer.

In case you missed it, this week we had news on the end of late-stage rocatinlimab OX40 development, FDA priority review of brepocitinib for dermatomyositis, phase 3 trial data of cemiplimab, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

O’Donoghue, a respected dermatologist and educator, left a lasting impact through her leadership, scholarship, and dedication to family and faith.

The on-demand format of podcasts allows learners at all levels to engage with expert insights conveniently.